Browse

You are looking at 51 - 100 of 244 items for :

  • Educational & Training x
  • Refine by Access: All content x
Clear All
Restricted access

CH 1.2 Medication Dosing in Overweight and Obese Patients

John E. Murphy

Restricted access

CH 2.2 Medication Dosing in Overweight and Obese Patients

John E. Murphy

Restricted access

4 MEDICATION DOSING IN OVERWEIGHT AND OBESE PATIENTS

Brian L. Erstad

Restricted access

25 Men’s Health

Mary Lee and Roohollah Sharifi

Restricted access

6 Pharmacogenetics and Molecular Testing

Jason H. Karnes and Laura B. Ramsey

Restricted access

5 PHARMACOGENOMIC IMPACTS ON PHARMACOKINETICS

Cheryl D. Cropp

Restricted access

18 PHENOBARBITAL

Kimberly B. Tallian and Douglas M. Anderson

Restricted access

CH 1.10 Phenobarbital

John E. Murphy

Restricted access

CH 2.10 Phenobarbital

John E. Murphy

Restricted access

19 PHENYTOIN AND FOSPHENYTOIN

Wendy Cheng and Tony K.L. Kiang

Restricted access

CH 1.11 Phenytoin/Fosphenytoin

John E. Murphy

Restricted access

CH 2.11 Phenytoin/Fosphenytoin

John E. Murphy

Restricted access

4 Point-of-Care Testing

Lisa M. Cillessen, Heather Lyons-Burney, and Paul O. Gubbins

Restricted access

3 Primer on Drug Interferences with Test Results

Mary Lee

Restricted access

14 Pulmonary Function and Related Tests

Lori A. Wilken and Min J. Joo

Free access

1 RATIONAL USE OF DRUG CONCENTRATION MEASUREMENTS

John E. Murphy

Restricted access

CH 1.4 Renal Drug Dosing

John E. Murphy

Restricted access

CH 2.4 Renal Drug Dosing

John E. Murphy

Restricted access

3 RENAL DRUG DOSING CONCEPTS

Dean A. Van Loo and Thomas C. Dowling

Restricted access

10 Renal Function and Related Tests

Kimmy T. Nguyen

Restricted access

20 Rheumatic Diseases

Susan P. Bruce

Restricted access

SECTION 2: Specific Drugs and Drug Classes

John E. Murphy

Restricted access

PART II SYSTEM DISORDERS AND DIAGNOSTIC TESTS

Christopher J. Edwards and Brian L. Erstad

Restricted access

PART III TESTS FOR SPECIAL POPULATIONS

Christopher J. Edwards and Brian L. Erstad

Restricted access

20 THEOPHYLLINE

Catherine B. Hobart and Hanna Phan

Restricted access

CH 1.8 Unfractionated Heparin and Low Molecular Weight Heparins

John E. Murphy

Restricted access

CH 2.8 Unfractionated Heparin and Low Molecular Weight Heparins

John E. Murphy

Restricted access

15 UNFRACTIONATED HEPARIN, LOW-MOLECULAR-WEIGHT HEPARINS, AND FONDAPARINUX

A. Joshua Roberts, Hahyoon Kim, and William E. Dager

Restricted access

21 VALPROATE

Barry E. Gidal

Restricted access

CH 1.12 Valproic Acid

John E. Murphy

Restricted access

CH 2.12 Valproic Acid

John E. Murphy

Restricted access

22 VANCOMYCIN

Jeremiah J. Duby, Monica A. Donnelley, Chelsea L. Tasaka, and Brett H. Heintz

Restricted access

CH 1.13 Vancomycin

John E. Murphy

Restricted access

CH 2.13 Vancomycin

John E. Murphy

Restricted access

23 WARFARIN

Sara R. Vazquez

Restricted access

CH 1.14 Warfarin

John E. Murphy

Restricted access

CH 2.14 Warfarin

John E. Murphy

Restricted access

24 Women’s Health

Candi C. Bachour

Restricted access

Chapter 2 Anti-Infective Agents

Anthony J. Guarascio, Jarrett R. Amsden, and David E. Zimmerman

Restricted access

Chapter 3 Antiepileptic Agents

Caroline Der-Nigoghossian and Karen Berger

Restricted access

Chapter 4 Cardiovascular Disease

Jacqueline M. Lucey (Klootwyk), Amber E. King, Drayton A. Hammond, and Branden D. Nemecek

Restricted access

Chapter 10 Chronic Kidney Disease, Common Comorbidities, and Diabetes

Branden D. Nemecek

Restricted access
Cover Demystifying Drug Dosing in Renal Dysfunction

Demystifying Drug Dosing in Renal Dysfunction

Edited by Branden D. Nemecek and Drayton A. Hammond

Restricted access

Chapter 5 Oncology

Justin M. Julius and Karen M. Fancher

Restricted access

Chapter 7 Pain Management

Nicole M. Bohm and Emmeline Tran

Restricted access

Chapter 8 Pediatrics

Carolyn E. Ragsdale and Kathryn Givens Merkel

Restricted access

Chapter 6 Psychiatric Agents

Jessica L. Ho

Restricted access

Chapter 1 Renal Disease and Renal Replacement Therapy Overview

Erin Frazee Barreto and Branden D. Nemecek

Restricted access

Chapter 9 Special Populations

Kimberly A. Trobaugh, Alexander H. Flannery, and Melissa L. Thompson Bastin

Restricted access

Chapter 11 Therapeutic Plasma Exchange

Drayton A. Hammond and Kirstin J. Kooda